当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 现金流量表

以岭药业

(002603)

  

流通市值:235.03亿  总市值:285.19亿
流通股本:13.77亿   总股本:16.71亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,123,725,514.934,096,951,718.032,035,275,225.737,374,426,224.7
  收到的税费返还15,814,249.810,983,581.726,990,272.2247,073,709.95
  收到其他与经营活动有关的现金251,813,708.08194,952,597.89138,584,150.96158,373,979.78
  经营活动现金流入小计6,391,353,472.814,302,887,897.642,180,849,648.917,579,873,914.43
  购买商品、接受劳务支付的现金2,122,582,744.321,399,269,183.84677,161,326.982,567,642,112.51
  支付给职工以及为职工支付的现金1,272,351,615.07890,874,125.06503,019,539.82,028,935,181.76
  支付的各项税费619,939,181.53436,449,671.81251,072,394.8758,333,319.3
  支付其他与经营活动有关的现金1,098,240,962.85744,254,840.97409,499,279.921,613,950,129.75
  经营活动现金流出小计5,113,114,503.773,470,847,821.681,840,752,541.56,968,860,743.32
  经营活动产生的现金流量净额1,278,238,969.04832,040,075.96340,097,107.41611,013,171.11
二、投资活动产生的现金流量:
  收回投资收到的现金893,000,000793,000,000280,000,0004,038,400,000
  取得投资收益收到的现金1,473,331.581,159,120.01127,334.14117,404,565.01
  处置固定资产、无形资产和其他长期资产收回的现金净额41,637.1741,637.17-20,062.62
  投资活动现金流入小计894,514,968.75794,200,757.18280,127,334.144,155,824,627.63
  购建固定资产、无形资产和其他长期资产支付的现金172,041,905.9587,657,764.7638,707,141.73290,390,861.8
  投资支付的现金1,803,500,0001,353,500,000439,800,0002,253,400,000
  投资活动现金流出小计1,975,541,905.951,441,157,764.76478,507,141.732,543,790,861.8
  投资活动产生的现金流量净额-1,081,026,937.2-646,957,007.58-198,379,807.591,612,033,765.83
三、筹资活动产生的现金流量:
  取得借款收到的现金---870,000,000
  收到其他与筹资活动有关的现金---312,500,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---1,182,500,000
  偿还债务支付的现金---2,269,700,000
  分配股利、利润或偿付利息支付的现金---375,305,427.14
  支付其他与筹资活动有关的现金7,307,247.285,423,118.14293,760790,677,738.58
  筹资活动现金流出小计7,307,247.285,423,118.14293,7603,435,683,165.72
  筹资活动产生的现金流量净额-7,307,247.28-5,423,118.14-293,760-2,253,183,165.72
四、汇率变动对现金及现金等价物的影响234,642.31143,861.5181,373.65105,273.7
五、现金及现金等价物净增加额190,139,426.87179,803,811.75141,504,913.47-30,030,955.08
  加:期初现金及现金等价物余额816,603,174.4816,603,174.4816,603,174.4846,634,129.48
  期末现金及现金等价物余额1,006,742,601.27996,406,986.15958,108,087.87816,603,174.4
补充资料:
  净利润-665,298,290.44--734,183,532.26
  资产减值准备-22,155,438.01-258,634,321.14
  固定资产和投资性房地产折旧-283,598,507.86-567,258,960.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-283,598,507.86-567,258,960.64
  无形资产摊销-14,285,571.65-34,183,590.66
  长期待摊费用摊销-1,261,525.8-2,503,572.5
  处置固定资产、无形资产和其他长期资产的损失--14,191.17-487,181.84
  固定资产报废损失---662,733.38
  财务费用-401,838.23-27,551,220.67
  投资损失--1,153,911.22--44,866,293.04
  递延所得税-56,494,805.31--198,147,018.29
  其中:递延所得税资产减少-58,355,936.27--182,256,954.56
    递延所得税负债增加--1,861,130.96--15,890,063.73
  存货的减少-259,403,092.16-470,315,349.57
  经营性应收项目的减少--437,072,295.63-638,252,197.66
  经营性应付项目的增加--36,252,562.16--447,299,507.65
  其他---25,550,920.26
  现金的期末余额-996,406,986.15-816,603,174.4
  减:现金的期初余额-816,603,174.4-846,634,129.48
  现金及现金等价物的净增加额-179,803,811.75--30,030,955.08
公告日期2025-10-282025-08-282025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑